• 1
    Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220: 391-398.
  • 2
    Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Schwartz GF, Giuliano AE, Veronesi U; Cancer. 2002; 94: 2542-2551.
  • 3
    Mabry H, Giuliano AE. Sentinel node mapping for breast cancer: progress to date and prospects for the future. Surg Oncol Clin North Am. 2007; 16: 55-70.
  • 4
    Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999; 85: 2433-2438.
  • 5
    Grube BJ, Christy CJ, Black D, et al. Breast sentinel lymph node dissection before preoperative chemotherapy. Arch Surg. 2008; 143: 692-699.
  • 6
    Tew K, Irwig L, Matthews A, et al. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005; 92: 1068-1080.
  • 7
    Brogi E, Torres-Matundan E, Tan LK, et al. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol. 2006; 12: 173-180.
  • 8
    McLaughlin SA, Ochoa-Frongia LM, Patil SM, et al. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. J Am Coll Surg. 2008; 206: 76-82.
  • 9
    Krishnamurthy S, Meric-Bernstam F, Lucci A, et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer. 2009; 115: 1555-1562.
  • 10
    Litz CE, Beitsch PD, Roberts CA, et al. Intraoperative cytological diagnosis of breast sentinel nodes in the routine, non-academic setting: a highly specific test with limited sensitivity. Breast J. 2004; 10: 383-387.
  • 11
    Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
  • 12
    Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007; 13: 4808-4816.
  • 13
    Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008; 122: 2562-2567.
  • 14
    Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the 1-step nucleic acid amplification assay. Clin Cancer Res. 2009; 15: 2879-2884.
  • 15
    Mori Y, Kitao M, Tomita N, et al. Real-time turbidimetry of LAMP reaction for quantifying template DNA. J Biochem Biophys Methods. 2004; 59: 145-157.
  • 16
    Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA [serial online]. Nucleic Acids Res. 2000; 28: E63.
  • 17
    Nagamine K, Hase T, Notomi T. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes. 2002; 16: 223-229.
  • 18
    Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008; 247: 136-142.
  • 19
    Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol. 2008; 26: 3338-3345.
  • 20
    Martinez M, Veys I, Majjaj S, et al. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol. 2009; 35: 387-392.
  • 21
    Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23: 7703-7720.
  • 22
    Wasif N, Ye X, Giuliano AE. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty. Ann Surg Oncol. 2009; 16: 2442-2449.
  • 23
    Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection in patients with or without axillary dissection in patients with sentinel lymph node metastasis: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252:426-432.